Home >> Machinery >> Machinery >> General Agriculture >> Public Sector >>

Global Recombinant Human Insulin Industry 2015 Deep Research Report

Published: Jan-2015 | Format: PDF | Research | Number of pages: 178 | Code: MRS - 7319

For overview analysis, the report introduces Recombinant Human Insulin basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.


For international and China market analysis, the report analyzes Recombinant Human Insulin markets in China and other countries or regions (such as US, Russia, etc.) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company

For technical data and manufacturing plants analysis, the report analyzes Recombinant Human Insulin leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.


This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.


In the end, the report includes Recombinant Human Insulin new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Recombinant Human Insulin industry. Here, we express our thanks for the support and assistance from Recombinant Human Insulin industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

 

 

 

 

 

Table of Contents

Chapter One Recombinant Human Insulin Industry Overview    1
1.1 Recombinant Human Insulin Definition  1
1.2 Recombinant Human Insulin Classification    2
1.3 Recombinant Human Insulin Industry Chain Structure  2
1.4 Recombinant Human Insulin Industry Overview    2
1.5 Recombinant Human Insulin Industry Policy Analysis   3
1.6 Recombinant Human Insulin Industry News Analysis    5

Chapter Two Recombinant Human Insulin International and China Market Analysis  7
2.1 Recombinant Human Insulin Industry International Market Analysis    7
2.1.1 Recombinant Human Insulin International Market Development History  7
2.1.2 Recombinant Human Insulin Product and Technology Developments       7
2.1.3 Recombinant Human Insulin International Competitive Landscape Analysis     9
2.1.4 Recombinant Human Insulin International Key Countries Development Status 10
2.1.5 Recombinant Human Insulin International Market Development Trend    11
2.2 Recombinant Human Insulin Industry China Market Analysis      11
2.2.1 Recombinant Human Insulin China Market Development History     11
2.2.2 Recombinant Human Insulin Product and Technology Developments       12
2.2.3 Recombinant Human Insulin China Competitive Landscape Analysis 13
2.2.4 Recombinant Human Insulin China Key Regions Development Status      14
2.2.5 Recombinant Human Insulin China Market Development Trend       15
2.3 Recombinant Human Insulin International and China Market Comparison Analysis    15

Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis       16
3.1 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production       16
3.2 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources Analysis  16

Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption 18
4.1 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption  18
4.2 2009-2014 India Recombinant Human Insulin Supply Import Export Consumption   18
4.3 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption    19
4.4 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption 19
4.5 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption  19
4.6 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption  20

Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure      21
5.1 Recombinant Human Insulin Product Specifications     21
5.1.1 Novo Nordisk Recombinant Human Insulin Product Specifications   21
5.1.2 Lilly Recombinant Human Insulin Product Specifications  22
5.2 Recombinant Human Insulin Manufacturing Process Analysis      22
5.3 Recombinant Human Insulin Cost Structure Analysis    23
5.4 Recombinant Human Insulin Cost Analysis    24

Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast     25
6.1 2009-2014 Recombinant Human Insulin Capacity Production (Million Pcs) Overview       25
6.2 2009-2014 Recombinant Human Insulin Production Market Share Analysis 32
6.3 2009-2014 Recombinant Human Insulin Demand Overview 43
6.4 2009-2014 Recombinant Human Insulin Supply Demand and Shortage       45
6.5 2009-2014 Recombinant Human Insulin Import Export Consumption  45
6.6 2009-2014 Recombinant Human Insulin Cost Price Production Value Gross Margin   46

Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis  47
7.1 Novo Nordisk   47
7.1.1 Company Profile   47
7.1.2 Novo Nordisk Recombinant Human Insulin Product Picture and Specification 50
7.1.3 Novo Nordisk Recombinant Human Insulin Capacity Production Price Cost Production Value     50
7.1.4 Contact Information     51
7.2 Eli Lilly    52
7.2.1 Company Profile   52
7.2.2 Eli Lilly Recombinant Human Insulin Product Picture and Specification  55
7.2.3 Eli Lilly Recombinant Human Insulin Capacity Production Price Cost Production Value 56
7.2.4 Contact Information     57
7.3 Bioton      59
7.3.1 Company Profile   59
7.3.2 Bioton Recombinant Human Insulin Product Picture and Specification    59
7.3.3 Bioton Recombinant Human Insulin Capacity Production Price Cost Production Value   62
7.3.4 Contact Information     63
7.4 Dongbao   64
7.4.1 Company Profile   64
7.4.2 Dongbao Recombinant Human Insulin Product Picture and Specification 65
7.4.3 Dongbao Recombinant Human Insulin Capacity Production Price Cost Production Value       68
7.4.4 Contact Information     69
7.5 United Laboratories (TUL)      69
7.5.1 Company Profile   69
7.5.2 United Laboratories Recombinant Human Insulin Product Picture and Specification       73
7.5.3 United Laboratories Recombinant Human Insulin Capacity Production Price Cost Production Value      75
7.5.4 Contact Information     76

Chapter Eight Up and Down Stream Industry Analysis       78
8.1 Upstream Raw Materials Price Analysis  78
8.2 Upstream Equipment Market Analysis    78
8.3 Down Stream Demand Analysis      80
8.4 Industry Chain Analysis   81

Chapter Nine Recombinant Human Insulin Marketing Channels Analysis   82
9.1 Recombinant Human Insulin Marketing Channels Status      82
9.2 Recombinant Human Insulin Marketing Channels Characteristic   82
9.3 Recombinant Human Insulin Marketing Channels Development Trend 83

Chapter Ten Recombinant Human Insulin Industry Development Trend     88
10.1 2015-2020 Recombinant Human Insulin Capacity Production Overview    88
10.2 2015-2020 Recombinant Human Insulin Production Market Share Analysis      90
10.3 2015-2020 Recombinant Human Insulin Demand Overview       94
10.4 2015-2020 Recombinant Human Insulin Supply Demand and Shortage     95
10.5 2015-2020 Recombinant Human Insulin Import Export Consumption       95
10.6 2015-2020 Recombinant Human Insulin Cost Price Production Value Gross Margin 96

Chapter Eleven Recombinant Human Insulin Industry Development Proposals  97
11.1 Macroeconomic Development Countermeasures   97
11.1.1 Macroeconomic policy       98
11.1.2 Specific control measures   99
11.2 New Firms Enter Market Strategy 100
11.3 New Project Investment Proposals 102
11.4 Marketing Channel Strategy Proposals  103
11.5 Competitive Environment Strategy Proposals      104

Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis 105
12.1 Recombinant Human Insulin Project SWOT Analysis  105
12.2 Recombinant Human Insulin New Project Investment Feasibility Analysis 105
12.2.1 Project Name      105
12.2.2 Investment Budget      105
12.2.3 Project Schedule 106
12.2.4 Benefit Analysis of Project 106

Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions     108


Tables and Figures


Figure Recombinant Human Insulin product picture    1
Table Recombinant Human Insulin Classification 2
Figure Recombinant Human Insulin Industry Chain Structure    2
Figure 2013 International Recombinant Human Insulin Major Manufacturers Production Share      9
Figure 2013 Recombinant Human Insulin International Key Countries Production Share  10
Figure 2015-2020 Recombinant Human Insulin International Capacity Production and Growth Rate      11
Figure 2013 Recombinant Human Insulin China Key Regions Production Share       13
Figure 2013 Recombinant Human Insulin China Key Regions Production Share       14
Figure 2015-2020 Recombinant Human Insulin China Capacity Production and Growth Rate  15
Figure 2009-2014 International and China Capacity Production Comparison     15
Table 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production (Million Pcs) Date     16
Table 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources List     16
Table 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption (Million Pcs) 18
Table 2009-2014 India Supply Import Export Consumption (Million Pcs) 18
Table 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)  19
Table 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)      19
Table 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)       19
Table 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)       20
Figure Recombinant Human Insulin Manufacturing Process       23
Figure Recombinant Human Insulin Cost Structure Analysis      24
Figure Recombinant Human Insulin Cost Analysis      24
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List  25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity Market Share List 25
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List   26
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share List     26
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    26
Table 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate List 26
Figure 2009-2014 Global Recombinant Human Insulin Capacity (Million Pcs) and Production Growth Rate  27
Figure 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate     27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List   27
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity Market Share List  28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List    28
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Market Share List      28
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate     29
Table 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate List  29
Figure 2009-2014 China Recombinant Human Insulin Capacity and Production Growth Rate  29
Figure 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate      30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List  30
Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value Market    30
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List  31
Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value Market Share List    31
Figure 2009 Global Major Manufacturers Recombinant Human Insulin Production Market Share    32
Figure 2009 China Major Manufacturers Recombinant Human Insulin Production Market Share     33
Figure 2010 Global Major Manufacturers Recombinant Human Insulin Production Market Share    34
Figure 2010 China Major Manufacturers Recombinant Human Insulin Production Market Share     35
Figure 2011 Global Major Manufacturers Recombinant Human Insulin Production Market Share    36
Figure 2011 China Major Manufacturers Recombinant Human Insulin Production Market Share     37
Figure 2012 Global Major Manufacturers Recombinant Human Insulin Production Market Share    38
Figure 2012 China Major Manufacturers Recombinant Human Insulin Production Market Share     39
Figure 2013 Global Major Manufacturers Recombinant Human Insulin Production Market Share    40
Figure 2013 China Major Manufacturers Recombinant Human Insulin Production Market Share     41
Figure 2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share    42
Figure 2014 China Major Manufacturers Recombinant Human Insulin Production Market Share     43
Table 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) List     43
Figure 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate     44
Table 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) List      44
Figure 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate      44
Table 2009-2014 Global Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List 45
Table 2009-2014 China Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List  45
Table 2009-2014 China Recombinant Human Insulin Import Export Consumption (Million Pcs)     45
Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List       46
Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List       46
Figure Novo Nordisk Network      48
Figure Novo Nordisk works with five strategic focus areas based on five core capabilities       48
Figure Global manufacturing setup       49
Figure Novo Nordisk’s position is protected by patents and value chain setup    49
Figure Novo Nordisk Recombinant Human Insulin Product Picture and Specification      50
Table 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List     50
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate      51
Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Production Global Market Share     51
Figure Eli Lilly Recombinant Human Insulin Product Picture and Specification       56
Table 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List       56
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate       57
Figure 2009-2014 Eli Lilly Recombinant Human Insulin Production Global Market Share      57
Figure Bioton Million Pcs Gensulin M30 Recombinant Human Insulin Product Picture and Specification      61
Table 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List  62
Figure 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate      62
Figure 2009-2014 Bioton Recombinant Human Insulin Production Global Market Share  63
Figure Dongbao Gansulin R Recombinant Human Insulin Product Picture and Specification   65
Figure Dongbao Gansulin N Recombinant Human Insulin Product Picture and Specification   66
Figure Dongbao Gansulin 30R Recombinant Human Insulin Product Picture and Specification       67
Table 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List       68
Figure 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate      68
Figure 2009-2014 Dongbao Recombinant Human Insulin Production Global Market Share     69
Figure United Laboratories USLIN® N Recombinant Human Insulin Product Picture and Specification 73
Figure United Laboratories USLIN®50 Recombinant Human Insulin Product Picture and Specification 73
Figure United Laboratories USLIN®30 Recombinant Human Insulin Product Picture and Specification 74
Figure United Laboratories USLIN®R Recombinant Human Insulin Product Picture and Specification   74
Table 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List 75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate     75
Figure 2009-2014 United Laboratories Recombinant Human Insulin Production Global Market Share    76
Figure Fermenter Picture      78
Figure Extraction system and Separation equipment    79
Figure Air purification systems     80
Figure Cold storage       80
Table 2009-2014 the Number of Diabetes (Million) and Diabetes Required Recombinant Human Insulin (Million) and Diabetes Growth Rate   81
Figure Recombinant Human Insulin Industry Chain    81
Figure Recombinant Human Insulin Marketing Channels Status  82
Table Recombinant Human Insulin Marketing Channels Characteristic Overview      82
Figure Marketing Channels Characteristic    83
Figure Flat Sales Channel Forms a Glance   84
Figure Partnership-type Relationship Sales Channels Form a Glance  86
Figure the export trend Overview  86
Figure 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate   88
Figure 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate     89
Figure 2015 Global Recombinant Human Insulin Production Market Share      90
Figure 2020 Global Recombinant Human Insulin Production Market Share      91
Figure 2015 China Recombinant Human Insulin Production Market Share 92
Figure 2020 China Recombinant Human Insulin Production Market Share 93
Figure 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate     94
Figure 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate      94
Table 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List    95
Table 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List     95
Table 2015-2020 China Recombinant Human Insulin Import (Million Pcs) Export (Million Pcs) Consumption (Million Pcs)       95
Table 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List    96
Table 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List      96
Table Macroeconomic Development Countermeasures Analysis   97
Table New Firms Enter Market Strategy      100
Table New Project Investment Proposals      102
Figure Recombinant Human Insulin Marketing strategy recommendations 103
Table Recombinant Human Insulin Marketing Channel Strategy Proposals 104
Table Competitive Environment Strategy Proposals     104
Table Recombinant Human Insulin Project SWOT Analysis 105
Table 100 Million Pcs Recombinant Human Insulin Project Appraisal and Financing       106
Table 100 Million Pcs Recombinant Human Insulin Project Construction Period      106
Table Annual Output of 100 Million Pcs Recombinant Human Insulin Project Return on Investment and Feasibility Analysis       106

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2600 View Pricing